Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Amsterdam
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
168.95(c) 166.9(c) 167.8(c) 168.85(c) 169.8 Last
222 919 384 809 212 589 250 760 77 927 Volume
-0.82% -1.21% +0.54% +0.63% +0.56% Change
More quotes
Estimated financial data (e)
Sales 2021 8 761 M 10 425 M 10 425 M
Net income 2021 898 M 1 068 M 1 068 M
Net Debt 2021 1 130 M 1 345 M 1 345 M
P/E ratio 2021 30,0x
Yield 2021 1,54%
Sales 2022 9 268 M 11 028 M 11 028 M
Net income 2022 932 M 1 109 M 1 109 M
Net Debt 2022 758 M 902 M 902 M
P/E ratio 2022 30,8x
Yield 2022 1,63%
Capitalization 28 837 M 34 281 M 34 313 M
EV / Sales 2021 3,42x
EV / Sales 2022 3,19x
Nbr of Employees 21 313
Free-Float 91,0%
More Financials
Company
Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics,... 
Sector
Diversified Chemicals
Calendar
08/03 | 01:00amEarnings Release
More about the company
Ratings of Royal DSM N.V.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about ROYAL DSM N.V.
07/27ROYAL DSM N : Koninklijke DSM N.V., - DSM acquires next-generation eubiotics pla..
PU
07/27ROYAL DSM N : DSM Takes Full Control Of Biotechnology Start-Up Midori USA For $6..
MT
07/27ROYAL DSM N : DSM acquires next-generation eubiotics platform start-up
PU
07/27Koninklijke DSM N.V. acquired remaining 61.5% stake in Midori USA, Inc for $6..
CI
07/15ROYAL DSM N : DSM's global head office to move to Maastricht, the Netherlands
PU
07/13ROYAL DSM N : DSM to Exit Specialty Resins Supplier AOC
MT
07/13ROYAL DSM N : DSM informs market on the announced sale of AOC to Lone Star Funds..
PU
07/12DGAP-ADHOC : Covestro AG: Raised earnings outlook for 2021
DJ
06/23Royal DSM and Brains Bioceutical Form Exclusive Global Partnership to Unlock ..
CI
06/17ROYAL DSM N : DSM - repurchase of shares (14-15 June 2021)
PU
06/16ROYAL DSM N : to Redeem $607 Million Bond Ahead of Schedule
MT
06/16ROYAL DSM N : DSM concludes early redemption of €500 million bond
PU
06/16DSM Concludes Early Redemption of €500 Million Bond
CI
06/15Mile High Labs and Royal Dsm Announces Exclusive Strategic Partnership to Dev..
CI
06/15ROYAL DSM N : DSM - repurchase of shares (7-11 June 2021)
PU
More news
News in other languages on ROYAL DSM N.V.
07/27DSM neemt Amerikaanse startup Midori volledig over
07/13Minderheidsbelang van DSM in AOC verkocht
07/12DGAP-ADHOC : Covestro AG: Ergebnisausblick für 2021 angehoben
07/08Morgan Stanley verhoogt koersdoel DSM
07/07JPMorgan verhoogt koersdoel DSM
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Stock Trading Strategies
ROYAL DSM N.V. - 04/14
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | DSM | NL0000009827 | MarketScreener
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 168,85 €
Average target price 158,40 €
Spread / Average Target -6,19%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.19.92%34 281
BASF SE3.15%72 893
SHIN-ETSU CHEMICAL CO., LTD.-1.25%67 598
DUPONT DE NEMOURS, INC.5.60%39 959
EVONIK INDUSTRIES AG10.27%16 298
PIDILITE INDUSTRIES LIMITED30.22%15 737